科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2021/07/16 | 4,805 | 4,880 | 4,805 | 4,815 | -45 | -0.9% | 81,000 |
| 2021/07/15 | 4,895 | 4,960 | 4,840 | 4,860 | -10 | -0.2% | 118,900 |
| 2021/07/14 | 4,795 | 4,895 | 4,795 | 4,870 | +70 | +1.5% | 93,900 |
| 2021/07/13 | 4,815 | 4,830 | 4,800 | 4,800 | +5 | +0.1% | 76,400 |
| 2021/07/12 | 4,790 | 4,815 | 4,765 | 4,795 | +100 | +2.1% | 99,500 |
| 2021/07/09 | 4,640 | 4,715 | 4,630 | 4,695 | -15 | -0.3% | 125,500 |
| 2021/07/08 | 4,775 | 4,775 | 4,710 | 4,710 | -85 | -1.8% | 107,800 |
| 2021/07/07 | 4,760 | 4,795 | 4,725 | 4,795 | -25 | -0.5% | 104,500 |
| 2021/07/06 | 4,825 | 4,835 | 4,805 | 4,820 | +5 | +0.1% | 62,000 |
| 2021/07/05 | 4,860 | 4,895 | 4,815 | 4,815 | -45 | -0.9% | 96,000 |
| 2021/07/02 | 4,885 | 5,010 | 4,860 | 4,860 | +75 | +1.6% | 317,600 |
| 2021/07/01 | 4,760 | 4,815 | 4,750 | 4,785 | +25 | +0.5% | 97,900 |
| 2021/06/30 | 4,790 | 4,795 | 4,755 | 4,760 | -30 | -0.6% | 89,400 |
| 2021/06/29 | 4,790 | 4,815 | 4,765 | 4,790 | -45 | -0.9% | 79,800 |
| 2021/06/28 | 4,850 | 4,870 | 4,810 | 4,835 | +10 | +0.2% | 104,100 |
| 2021/06/25 | 4,840 | 4,850 | 4,790 | 4,825 | -5 | -0.1% | 91,800 |
| 2021/06/24 | 4,765 | 4,840 | 4,760 | 4,830 | +65 | +1.4% | 120,400 |
| 2021/06/23 | 4,755 | 4,810 | 4,755 | 4,765 | +5 | +0.1% | 115,700 |
| 2021/06/22 | 4,735 | 4,760 | 4,680 | 4,760 | +140 | +3% | 143,500 |
| 2021/06/21 | 4,650 | 4,665 | 4,605 | 4,620 | -120 | -2.5% | 129,700 |
| 2021/06/18 | 4,795 | 4,795 | 4,730 | 4,740 | -55 | -1.1% | 142,500 |
| 2021/06/17 | 4,770 | 4,810 | 4,765 | 4,795 | +40 | +0.8% | 108,500 |
| 2021/06/16 | 4,700 | 4,790 | 4,700 | 4,755 | ±0 | ±0% | 132,600 |
| 2021/06/15 | 4,820 | 4,835 | 4,755 | 4,755 | -65 | -1.3% | 114,800 |
| 2021/06/14 | 4,820 | 4,845 | 4,785 | 4,820 | +5 | +0.1% | 110,800 |
| 2021/06/11 | 4,795 | 4,815 | 4,765 | 4,815 | +50 | +1% | 139,200 |
| 2021/06/10 | 4,795 | 4,800 | 4,730 | 4,765 | +40 | +0.8% | 124,200 |
| 2021/06/09 | 4,710 | 4,795 | 4,710 | 4,725 | -10 | -0.2% | 120,700 |
| 2021/06/08 | 4,710 | 4,750 | 4,710 | 4,735 | +40 | +0.9% | 96,800 |
| 2021/06/07 | 4,650 | 4,710 | 4,650 | 4,695 | +45 | +1% | 119,300 |
| 2021/06/04 | 4,650 | 4,665 | 4,640 | 4,650 | +25 | +0.5% | 104,500 |
| 2021/06/03 | 4,650 | 4,670 | 4,600 | 4,625 | -25 | -0.5% | 221,000 |
| 2021/06/02 | 4,595 | 4,655 | 4,560 | 4,650 | +40 | +0.9% | 241,300 |
| 2021/06/01 | 4,570 | 4,620 | 4,570 | 4,610 | +80 | +1.8% | 235,700 |
| 2021/05/31 | 4,585 | 4,625 | 4,520 | 4,530 | -50 | -1.1% | 265,300 |
| 2021/05/28 | 4,545 | 4,590 | 4,530 | 4,580 | +70 | +1.6% | 249,500 |
| 2021/05/27 | 4,450 | 4,540 | 4,450 | 4,510 | +50 | +1.1% | 623,700 |
| 2021/05/26 | 4,455 | 4,490 | 4,430 | 4,460 | +5 | +0.1% | 158,200 |
| 2021/05/25 | 4,500 | 4,510 | 4,455 | 4,455 | -50 | -1.1% | 175,400 |
| 2021/05/24 | 4,500 | 4,510 | 4,435 | 4,505 | +5 | +0.1% | 159,900 |
| 2021/05/21 | 4,495 | 4,510 | 4,475 | 4,500 | -5 | -0.1% | 147,600 |
| 2021/05/20 | 4,530 | 4,570 | 4,500 | 4,505 | -20 | -0.4% | 130,700 |
| 2021/05/19 | 4,470 | 4,535 | 4,460 | 4,525 | +10 | +0.2% | 120,800 |
| 2021/05/18 | 4,480 | 4,515 | 4,455 | 4,515 | +10 | +0.2% | 135,900 |
| 2021/05/17 | 4,500 | 4,525 | 4,495 | 4,505 | -5 | -0.1% | 101,100 |
| 2021/05/14 | 4,490 | 4,545 | 4,475 | 4,510 | +55 | +1.2% | 83,900 |
| 2021/05/13 | 4,400 | 4,490 | 4,385 | 4,455 | +45 | +1% | 166,000 |
| 2021/05/12 | 4,510 | 4,555 | 4,400 | 4,410 | -140 | -3.1% | 212,200 |
| 2021/05/11 | 4,575 | 4,590 | 4,515 | 4,550 | -40 | -0.9% | 207,200 |
| 2021/05/10 | 4,540 | 4,610 | 4,505 | 4,590 | +45 | +1% | 141,600 |
951～
1000
件表示中 / 3715件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 378,500円 | -6.4% | -71.8% | 5.02% | 42.15倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| キッセイ薬 | 417,000円 | +3.6% | +6.1% | 2.88% | 14.05倍 | 0.83倍 |
|
医薬品中堅。泌尿器、腎・透析、未充足医療が重点領域。主軸特許切れ、新しい柱育成。海外は導出 |
| 鳥居薬 | 634,000円 | +7.1% | -35.0% | 0.00% | 52.43倍 | 1.47倍 |
|
ＪＴ傘下。柱の抗ＨＩＶ薬販売権喪失後、自社製品の腎・透析、アレルゲン等の開発強化 |
| 東和薬品 | 312,500円 | +7.9% | -3.3% | 2.56% | 8.69倍 | 0.90倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 204,600円 | +3.1% | -6.5% | 2.35% | 9.49倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
